<?xml version='1.0' encoding='utf-8'?>
<document id="32284380"><sentence text="Safety, Pharmacokinetics, and Drug:Drug Interaction Potential of Intravenous Durlobactam, a β-lactamase Inhibitor, in Healthy Subjects." /><sentence text="Durlobactam (DUR, also known as ETX2514) is a novel β-lactamase inhibitor with broad activity against Ambler class A, C, and D β-lactamases"><entity charOffset="0-11" id="DDI-PubMed.32284380.s2.e0" text="Durlobactam" /><entity charOffset="13-16" id="DDI-PubMed.32284380.s2.e1" text="DUR" /><entity charOffset="32-39" id="DDI-PubMed.32284380.s2.e2" text="ETX2514" /><pair ddi="false" e1="DDI-PubMed.32284380.s2.e0" e2="DDI-PubMed.32284380.s2.e0" /><pair ddi="false" e1="DDI-PubMed.32284380.s2.e0" e2="DDI-PubMed.32284380.s2.e1" /><pair ddi="false" e1="DDI-PubMed.32284380.s2.e0" e2="DDI-PubMed.32284380.s2.e2" /><pair ddi="false" e1="DDI-PubMed.32284380.s2.e1" e2="DDI-PubMed.32284380.s2.e1" /><pair ddi="false" e1="DDI-PubMed.32284380.s2.e1" e2="DDI-PubMed.32284380.s2.e2" /></sentence><sentence text=" Addition of DUR to sulbactam (SUL) in vitro restores SUL activity against clinical isolates of Acinetobacter baumannii The safety and pharmacokinetics (PK) of DUR alone and with SUL and/or imipenem/cilastatin (IMI/CIL) were evaluated in healthy subjects"><entity charOffset="20-29" id="DDI-PubMed.32284380.s3.e0" text="sulbactam" /><entity charOffset="31-34" id="DDI-PubMed.32284380.s3.e1" text="SUL" /><entity charOffset="190-198" id="DDI-PubMed.32284380.s3.e2" text="imipenem" /><entity charOffset="199-209" id="DDI-PubMed.32284380.s3.e3" text="cilastatin" /><entity charOffset="215-218" id="DDI-PubMed.32284380.s3.e4" text="CIL" /><entity charOffset="13-15" id="DDI-PubMed.32284380.s3.e5" text="DUR" /><entity charOffset="160-162" id="DDI-PubMed.32284380.s3.e6" text="DUR" /><entity charOffset="54-56" id="DDI-PubMed.32284380.s3.e7" text="SUL" /><entity charOffset="179-181" id="DDI-PubMed.32284380.s3.e8" text="SUL" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e5" e2="DDI-PubMed.32284380.s3.e5" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e5" e2="DDI-PubMed.32284380.s3.e0" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e5" e2="DDI-PubMed.32284380.s3.e1" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e5" e2="DDI-PubMed.32284380.s3.e7" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e5" e2="DDI-PubMed.32284380.s3.e6" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e5" e2="DDI-PubMed.32284380.s3.e8" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e5" e2="DDI-PubMed.32284380.s3.e2" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e5" e2="DDI-PubMed.32284380.s3.e3" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e5" e2="DDI-PubMed.32284380.s3.e4" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e0" e2="DDI-PubMed.32284380.s3.e0" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e0" e2="DDI-PubMed.32284380.s3.e1" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e0" e2="DDI-PubMed.32284380.s3.e7" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e0" e2="DDI-PubMed.32284380.s3.e6" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e0" e2="DDI-PubMed.32284380.s3.e8" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e0" e2="DDI-PubMed.32284380.s3.e2" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e0" e2="DDI-PubMed.32284380.s3.e3" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e0" e2="DDI-PubMed.32284380.s3.e4" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e1" e2="DDI-PubMed.32284380.s3.e1" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e1" e2="DDI-PubMed.32284380.s3.e7" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e1" e2="DDI-PubMed.32284380.s3.e6" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e1" e2="DDI-PubMed.32284380.s3.e8" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e1" e2="DDI-PubMed.32284380.s3.e2" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e1" e2="DDI-PubMed.32284380.s3.e3" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e1" e2="DDI-PubMed.32284380.s3.e4" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e7" e2="DDI-PubMed.32284380.s3.e7" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e7" e2="DDI-PubMed.32284380.s3.e6" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e7" e2="DDI-PubMed.32284380.s3.e8" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e7" e2="DDI-PubMed.32284380.s3.e2" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e7" e2="DDI-PubMed.32284380.s3.e3" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e7" e2="DDI-PubMed.32284380.s3.e4" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e6" e2="DDI-PubMed.32284380.s3.e6" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e6" e2="DDI-PubMed.32284380.s3.e8" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e6" e2="DDI-PubMed.32284380.s3.e2" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e6" e2="DDI-PubMed.32284380.s3.e3" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e6" e2="DDI-PubMed.32284380.s3.e4" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e8" e2="DDI-PubMed.32284380.s3.e8" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e8" e2="DDI-PubMed.32284380.s3.e2" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e8" e2="DDI-PubMed.32284380.s3.e3" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e8" e2="DDI-PubMed.32284380.s3.e4" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e2" e2="DDI-PubMed.32284380.s3.e2" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e2" e2="DDI-PubMed.32284380.s3.e3" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e2" e2="DDI-PubMed.32284380.s3.e4" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e3" e2="DDI-PubMed.32284380.s3.e3" /><pair ddi="false" e1="DDI-PubMed.32284380.s3.e3" e2="DDI-PubMed.32284380.s3.e4" /></sentence><sentence text=" This was a randomized, placebo-controlled study" /><sentence text=" In Part A, subjects including an elderly cohort (DUR 1 g) received single ascending doses of DUR 0"><entity charOffset="50-52" id="DDI-PubMed.32284380.s5.e0" text="DUR" /><entity charOffset="94-96" id="DDI-PubMed.32284380.s5.e1" text="DUR" /><pair ddi="false" e1="DDI-PubMed.32284380.s5.e0" e2="DDI-PubMed.32284380.s5.e0" /><pair ddi="false" e1="DDI-PubMed.32284380.s5.e0" e2="DDI-PubMed.32284380.s5.e1" /></sentence><sentence text="25-8 g" /><sentence text=" In Part B, multiple ascending dose of DUR 0"><entity charOffset="39-41" id="DDI-PubMed.32284380.s7.e0" text="DUR" /></sentence><sentence text="25-2 g were administered every 6 hours (q6h) for 29 doses" /><sentence text=" In Parts C and D, the drug-drug interaction (DDI) potential, including safety, of DUR (1 g) with SUL (1 g) and/or IMI/CIL (0"><entity charOffset="83-85" id="DDI-PubMed.32284380.s9.e0" text="DUR" /><entity charOffset="98-100" id="DDI-PubMed.32284380.s9.e1" text="SUL" /><entity charOffset="119-121" id="DDI-PubMed.32284380.s9.e2" text="CIL" /><pair ddi="false" e1="DDI-PubMed.32284380.s9.e0" e2="DDI-PubMed.32284380.s9.e0" /><pair ddi="false" e1="DDI-PubMed.32284380.s9.e0" e2="DDI-PubMed.32284380.s9.e1" /><pair ddi="false" e1="DDI-PubMed.32284380.s9.e0" e2="DDI-PubMed.32284380.s9.e2" /><pair ddi="false" e1="DDI-PubMed.32284380.s9.e1" e2="DDI-PubMed.32284380.s9.e1" /><pair ddi="false" e1="DDI-PubMed.32284380.s9.e1" e2="DDI-PubMed.32284380.s9.e2" /></sentence><sentence text="5/0" /><sentence text="5 g) was investigated after single and multiple doses" /><sentence text=" Plasma and urine concentrations of DUR, SUL, and IMI/CIL were determined"><entity charOffset="36-38" id="DDI-PubMed.32284380.s12.e0" text="DUR" /><entity charOffset="41-43" id="DDI-PubMed.32284380.s12.e1" text="SUL" /><entity charOffset="54-56" id="DDI-PubMed.32284380.s12.e2" text="CIL" /><pair ddi="false" e1="DDI-PubMed.32284380.s12.e0" e2="DDI-PubMed.32284380.s12.e0" /><pair ddi="false" e1="DDI-PubMed.32284380.s12.e0" e2="DDI-PubMed.32284380.s12.e1" /><pair ddi="false" e1="DDI-PubMed.32284380.s12.e0" e2="DDI-PubMed.32284380.s12.e2" /><pair ddi="false" e1="DDI-PubMed.32284380.s12.e1" e2="DDI-PubMed.32284380.s12.e1" /><pair ddi="false" e1="DDI-PubMed.32284380.s12.e1" e2="DDI-PubMed.32284380.s12.e2" /></sentence><sentence text=" Among 124 subjects, DUR was generally safe and well tolerated either alone or in combination with SUL and/or IMI/CIL"><entity charOffset="21-23" id="DDI-PubMed.32284380.s13.e0" text="DUR" /><entity charOffset="99-101" id="DDI-PubMed.32284380.s13.e1" text="SUL" /><entity charOffset="114-116" id="DDI-PubMed.32284380.s13.e2" text="CIL" /><pair ddi="false" e1="DDI-PubMed.32284380.s13.e0" e2="DDI-PubMed.32284380.s13.e0" /><pair ddi="false" e1="DDI-PubMed.32284380.s13.e0" e2="DDI-PubMed.32284380.s13.e1" /><pair ddi="false" e1="DDI-PubMed.32284380.s13.e0" e2="DDI-PubMed.32284380.s13.e2" /><pair ddi="false" e1="DDI-PubMed.32284380.s13.e1" e2="DDI-PubMed.32284380.s13.e1" /><pair ddi="false" e1="DDI-PubMed.32284380.s13.e1" e2="DDI-PubMed.32284380.s13.e2" /></sentence><sentence text=" After single and multiple doses, DUR demonstrated linear dose proportional exposure across the studied dose ranges"><entity charOffset="34-36" id="DDI-PubMed.32284380.s14.e0" text="DUR" /></sentence><sentence text=" Renal excretion was a predominant clearance mechanism" /><sentence text=" No drug:drug interaction potential was identified between DUR and SUL and/or IMI/CIL"><entity charOffset="59-61" id="DDI-PubMed.32284380.s16.e0" text="DUR" /><entity charOffset="67-69" id="DDI-PubMed.32284380.s16.e1" text="SUL" /><entity charOffset="82-84" id="DDI-PubMed.32284380.s16.e2" text="CIL" /><pair ddi="false" e1="DDI-PubMed.32284380.s16.e0" e2="DDI-PubMed.32284380.s16.e0" /><pair ddi="false" e1="DDI-PubMed.32284380.s16.e0" e2="DDI-PubMed.32284380.s16.e1" /><pair ddi="false" e1="DDI-PubMed.32284380.s16.e0" e2="DDI-PubMed.32284380.s16.e2" /><pair ddi="false" e1="DDI-PubMed.32284380.s16.e1" e2="DDI-PubMed.32284380.s16.e1" /><pair ddi="false" e1="DDI-PubMed.32284380.s16.e1" e2="DDI-PubMed.32284380.s16.e2" /></sentence><sentence text=" SUL-DUR, 1 g (of each component) administered q6h with a 3 hour IV infusion, is under development for the treatment of serious infections due to A"><entity charOffset="5-7" id="DDI-PubMed.32284380.s17.e0" text="DUR" /><entity charOffset="1-3" id="DDI-PubMed.32284380.s17.e1" text="SUL" /><pair ddi="false" e1="DDI-PubMed.32284380.s17.e1" e2="DDI-PubMed.32284380.s17.e1" /><pair ddi="false" e1="DDI-PubMed.32284380.s17.e1" e2="DDI-PubMed.32284380.s17.e0" /></sentence><sentence text=" baumannii" /><sentence text="" /></document>